"Gene therapy for cancer is becoming a reality but works best for blood cancers like leukemia and not yet in more common ones like lung cancer. The approval of gene therapy for leukemia, expected in the next few months, will open the door to a radically new class of cancer treatments.Companies and universities are racing to develop these new therapies, which re-engineer and turbocharge millions of a patient’s own immune cells, turning them into cancer killers that researchers call a “living drug.” One of the big goals now is to get them to work for many other cancers, including those of the breast, prostate, ovary, lung and pancreas.But it will take time to find that out, he said, at least five years"